National Institute of General Medical Sciences; Notice of Closed Meetings, 19742 [2017-08629]
Download as PDF
19742
Federal Register / Vol. 82, No. 81 / Friday, April 28, 2017 / Notices
double-spaced. All nomination
materials should be submitted
(postmarked or received) by May 30,
2017.
Electronic submissions: Nomination
materials, including attachments, may
be submitted electronically to cfsac@
hhs.gov. An email from the CFSAC
Support Team will be sent to the
nominating organization and/or
nominator to confirm receipt of the
nomination. If the email confirmation is
not received within two working days,
please call 202–690–7650. Telephone
and facsimile submissions cannot be
accepted.
Regular, Express, or Overnight Mail:
Written documents may be submitted to
the following addressee only:
Commander Gustavo Ceinos, Designated
Federal Officer, CFSAC, Office on
Women’s Health, Department of Health
and Human Services, 200 Independence
Avenue SW., Room 728F.6, Washington,
DC 20201.
HHS makes every effort to ensure that
the membership of federal advisory
committees is fairly balanced in terms of
points of view represented. Every effort
is made to ensure that a broad
representation of geographic areas, sex,
ethnic and minority groups, and people
with disabilities are given consideration
for membership on federal advisory
committees. Selection of the represented
organizations shall be made without
discrimination against the composition
of an organization’s membership on the
basis of age, sex, race, ethnicity, sexual
orientation, disability, and cultural,
religious, or socioeconomic status.
Authority: 42 U.S.C. 217a, section 222 of
the Public Health Service (PHS) Act, as
amended. The Committee is governed by the
provisions of the Federal Advisory
Committee Act, as amended (5 U.S.C. App 2),
which sets forth standards for the formation
and use of advisory committees.
Dated: April 18, 2017.
Nicole Greene,
Acting Director, Office on Women’s Health.
[FR Doc. 2017–08383 Filed 4–27–17; 8:45 am]
BILLING CODE 4150–42–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
asabaliauskas on DSK3SPTVN1PROD with NOTICES
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
VerDate Sep<11>2014
17:38 Apr 27, 2017
Jkt 241001
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Peer-Review of (SCORE) Advancement
Award.
Date: June 23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Cambria Suites Rockville, I Helen
Heneghan Way, Rockville, MD 20850.
Contact Person: Manas Chattopadhyay,
Ph.D., Scientific Review Officer, Office of
Scientific Review, National Institute of
General Medical Sciences, National Institutes
of Health, Building 45, Room 3An12N, 45
Center Drive, Bethesda, MD 20892, 301–827–
5320, manasc@mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Centers of Biomedical Research
Excellence (COBRE) (P20).
Date: June 29, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Cambria Suites Rockville, 1 Helen
Heneghan Way, Rockville, MD 20850.
Contact Person: Shinako Takada, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3AN18, Bethesda, MD
20892–6200, 301–402–9448,
shinako.takada@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859,
Biomedical Research and Research Training,
National Institutes of Health, HHS)
Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–08629 Filed 4–27–17; 8:45 am]
National Institutes of Health
National Institute of Mental Health;
Notice of Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Interventions and Biomarkers Special
Emphasis Panel.
Date: May 24, 2017.
Time: 11:00 a.m. to 1:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Telephone
Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
Name of Committee: National Institute of
Mental Health Special Emphasis Panel;
Confirmatory Efficacy Clinical Trials of NonPharmacological Interventions for Mental
Disorders.
Date: May 24, 2017.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6100
Executive Boulevard, Rockville, MD 20852
(Telephone Conference Call).
Contact Person: Marcy Ellen Burstein,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, National Institute of
Mental Health, NIH, Neuroscience Center,
6001 Executive Blvd., Room 6143, MSC 9606,
Bethesda, MD 20892–9606, 301–443–9699,
bursteinme@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program No. 93.242, Mental Health Research
Grants, National Institutes of Health, HHS)
Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
PO 00000
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–08630 Filed 4–27–17; 8:45 am]
BILLING CODE 4140–01–P
Frm 00091
Fmt 4703
Sfmt 9990
E:\FR\FM\28APN1.SGM
28APN1
Agencies
[Federal Register Volume 82, Number 81 (Friday, April 28, 2017)]
[Notices]
[Page 19742]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-08629]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of General Medical Sciences; Notice of Closed
Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Peer-Review of (SCORE) Advancement
Award.
Date: June 23, 2017.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Cambria Suites Rockville, I Helen Heneghan Way,
Rockville, MD 20850.
Contact Person: Manas Chattopadhyay, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, Building 45, Room
3An12N, 45 Center Drive, Bethesda, MD 20892, 301-827-5320,
manasc@mail.nih.gov.
Name of Committee: National Institute of General Medical
Sciences Special Emphasis Panel; Centers of Biomedical Research
Excellence (COBRE) (P20).
Date: June 29, 2017.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Cambria Suites Rockville, 1 Helen Heneghan Way,
Rockville, MD 20850.
Contact Person: Shinako Takada, Ph.D., Scientific Review
Officer, Office of Scientific Review, National Institute of General
Medical Sciences, National Institutes of Health, 45 Center Drive,
Room 3AN18, Bethesda, MD 20892-6200, 301-402-9448,
shinako.takada@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.375,
Minority Biomedical Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology, Physiology, and
Biological Chemistry Research; 93.862, Genetics and Developmental
Biology Research; 93.88, Minority Access to Research Careers; 93.96,
Special Minority Initiatives; 93.859, Biomedical Research and
Research Training, National Institutes of Health, HHS)
Dated: April 25, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-08629 Filed 4-27-17; 8:45 am]
BILLING CODE 4140-01-P